Madrona Financial Services »

Lineage Cell Therapeutics In shares owned by Madrona Financial Services

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Madrona Financial Services from 13F filings

Historical chart of Madrona Financial Services investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Madrona Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Madrona Financial Services

Quarter filed Position value Share count Share price at filing
2024-09-30 $14k 15k 0.91
2024-06-30 $15k 15k 1.00
2024-03-31 $22k 15k 1.48
2023-12-31 $16k 15k 1.09

More positions owned by Madrona Financial Services

Invesco Qqq Tr Unit Ser 1 (QQQ)
Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
First Tr Exchange-traded Dorsey Wrt 5 Etf (FV)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Ishares Tr S&p 500 Grwt Etf (IVW)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Northern Lts Fd Tr Iv Main Buywrite (BUYW)
Pacer Fds Tr Pacer Us Small (CALF)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Apple (AAPL)
First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Pacer Fds Tr Developed Mrkt (ICOW)

View all positions for Madrona Financial Services

Top funds holding Lineage Cell Therapeutics In

BlackRock
BlackRock
Vanguard Group
Defender Capital
Logos Global Management
Raffles Associates
Geode Capital Management
State Street Corporation
MAI Wealth Advisors
Bank of America Corporation
DAFNA Capital Management
Northern Trust
Bridgeway Capital Management
Jpmorgan Chase & Co
Morgan Stanley

View all funds holding Lineage Cell Therapeutics In